LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Liquidia Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$34.13−0.22 (-0.64%)
Close on Oct 19, 2026
- Market cap
- $3.46B
- P/E (TTM)
- 24.6
- Dividend yield
- –
Liquidia Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- 37.4%
- Net margin
- 30.7%
- Return on equity, FY2025
- -111.1%
Financial strength
- Current ratio
- 2.31
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 150.1%
Valuation
- P/E ratio
- 24.6
- Price to sales
- 7.67
- Price to book
- 17.74
- Dividend yield
- –